3/13
12:18 pm
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
3/13
11:30 am
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
3/13
11:30 am
zvra
Rating for ZVRA
Low
Report
Rating for ZVRA
3/13
08:00 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
3/12
10:33 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
Medium
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
3/12
10:13 am
zvra
Rating for ZVRA
Medium
Report
Rating for ZVRA
3/12
09:12 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
1/30
07:28 am
zvra
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Low
Report
Zevra Therapeutics, Inc. (NASDAQ: ZVRA) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.